Performance of TXG 10X Genomics | -52.4% in 12m
Compare TXG with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare 10X Genomics with its related Sector/Index XLV
Performance Duell TXG vs XLV
| TimeFrame | TXG | XLV |
|---|---|---|
| 1 Day | -2.27% | 0.19% |
| 1 Week | -3.77% | 1.89% |
| 1 Month | -14.2% | 5.68% |
| 3 Months | -48.4% | 0.84% |
| 6 Months | -40.7% | 15.01% |
| 12 Months | -52.4% | 13.50% |
| YTD | -53.9% | 5.81% |
| Rel. Perf. 1m | -2.09 | |
| Rel. Perf. 3m | -7.69 | |
| Rel. Perf. 6m | -5.73 | |
| Rel. Perf. 12m | -8.72 |
Is 10X Genomics a good stock to buy?
No, based on ValueRay Fundamental Analyses, 10X Genomics (NASDAQ:TXG) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -56.77 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TXG as of May 2024 is 20.00. This means that TXG is currently overvalued and has a potential downside of -20.03% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TXG as of May 2024 is 20.00. This means that TXG is currently overvalued and has a potential downside of -20.03% (Sold with Premium).
Is TXG a buy, sell or hold?
- Strong Buy: 8
- Buy: 4
- Hold: 3
- Sell: 1
- Strong Sell: 0
Values above 0%: TXG is performing better - Values below 0%: TXG is underperforming
Compare TXG with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -5.42% | -20.00% | -58.98% | -81.75% |
| US NASDAQ 100 | QQQ | -5.96% | -20.32% | -58.16% | -89.75% |
| US Dow Jones Industrial 30 | DIA | -5.13% | -20.40% | -56.16% | -74.42% |
| German DAX 40 | DBXD | -3.37% | -19.20% | -57.68% | -69.17% |
| UK FTSE 100 | ISFU | -5.27% | -24.03% | -57.55% | -67.77% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.88% | -18.75% | -44.02% | -44.73% |
| Hongkong Hang Seng | HSI | -7.50% | -37.51% | -45.73% | -47.04% |
| Japan Nikkei 225 | EXX7 | -4.14% | -13.73% | -52.18% | -64.21% |
| India NIFTY 50 | INDA | -6.88% | -18.15% | -58.27% | -81.12% |
| Brasil Bovespa | EWZ | -4.21% | -19.47% | -38.86% | -64.73% |
TXG 10X Genomics vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.77% | -17.54% | -59.20% | -89.88% |
| Consumer Discretionary | XLY | -4.11% | -17.93% | -48.03% | -72.07% |
| Consumer Staples | XLP | -4.53% | -20.81% | -54.93% | -57.98% |
| Energy | XLE | -4.97% | -15.11% | -54.81% | -77.62% |
| Financial | XLF | -5.35% | -21.28% | -63.11% | -85.47% |
| Health Care | XLV | -5.66% | -19.91% | -55.70% | -65.90% |
| Industrial | XLI | -3.49% | -17.71% | -60.38% | -80.73% |
| Materials | XLB | -4.11% | -17.77% | -56.71% | -73.02% |
| Real Estate | XLRE | -6.28% | -22.71% | -50.33% | -62.38% |
| Technology | XLK | -6.83% | -20.75% | -57.01% | -90.71% |
| Utilities | XLU | -5.27% | -27.12% | -58.89% | -65.08% |
| Aerospace & Defense | XAR | -4.54% | -22.69% | -56.23% | -76.55% |
| Biotech | XBI | -7.22% | -21.94% | -66.20% | -58.77% |
| Homebuilder | XHB | -3.45% | -20.57% | -71.20% | -103.25% |
| Retail | XRT | -5.85% | -21.69% | -61.53% | -77.59% |
Does 10X Genomics outperform its market, is TXG a Sector Leader?
No, over the last 12 months 10X Genomics (TXG) made -52.40%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 13.50%.
Over the last 3 months TXG made -48.38%, while XLV made 0.84%.
No, over the last 12 months 10X Genomics (TXG) made -52.40%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 13.50%.
Over the last 3 months TXG made -48.38%, while XLV made 0.84%.
| Period | TXG | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -14.23% | 5.68% | 5.77% |
| 3 Months | -48.38% | 0.84% | 6.32% |
| 12 Months | -52.40% | 13.50% | 29.35% |